Tekmira definition

Tekmira means Tekmira Pharmaceuticals Corporation.
Tekmira means Tekmira Pharmaceuticals Corporation, predecessor to Arbutus.
Tekmira shall have the meaning set forth in the PadCo-Protiva License and Services Agreement.

Examples of Tekmira in a sentence

  • While Tekmira considers these assumptions to be reasonable, these assumptions are inherently subject to significant business, economic, competitive, market and social uncertainties and contingencies.

  • All forward-looking statements herein are qualified in their entirety by this cautionary statement, and Tekmira disclaims any obligation to revise or update any such forward-looking statements or to publicly announce the result of any revisions to any of the forward-looking statements contained herein to reflect future results, events or developments, except as required by law.

  • Therefore, the Court gives little weight to the precedential value of the Nortel bankruptcy case.In Tekmira Pharmaceuticals Corp.

  • Alnylam Pharmaceuticals, Inc., Malackowski also performed a “cost-based apportionment metric.” Filing No. 337, at 38; Filing No. 337-6 (citing Tekmira Pharmaceuticals Corp.

  • Tekmira believes its LNP technology represents the most widely adopted delivery technology for the systemic delivery of RNAi therapeutics.

  • Therefore, the Court gives little weight to the precedential value of the Tekmira case.The Court agrees with the defendants that Malackowski’s methodology and model has never before been attempted.

  • In fact, it appears as though Malackowski did not apply revenues into his calculations in the Tekmira case.

  • About Tekmira Tekmira Pharmaceuticals Corporation is a biopharmaceutical company focused on advancing novel RNAi therapeutics and providing its leading lipid nanoparticle delivery technology to pharmaceutical partners.

  • The shares reserved for issue on the exercise of these options is equal to the number of Tekmira common shares that would have been issued if the options had been exercised before the completion of the business combination and the shares issued on exercise of the options had then been exchanged for Tekmira common shares.

  • Tekmira has been working in the field of nucleic acid delivery for over a decade and has broad intellectual property covering LNPs. Further information about Tekmira can be found at xxx.xxxxxxxxxxxx.xxx.


More Definitions of Tekmira

Tekmira acquired the business of INEX in 2007. As such, all references to “Inex Pharmaceuticals Corporation” or “INEX” are deleted in their entirety and replaced with “Tekmira Pharmaceuticals Corporation” or “TEKMIRA”, as applicable.
Tekmira includes, as the context may require, its affiliates, subsidiaries, associated companies, successors, and assigns.
Tekmira means Tekmira Pharmaceuticals Corporation (formerly INEX Pharmaceuticals Corporation).

Related to Tekmira

  • ISIS means the department’s individualized services information system.

  • Novartis shall have the meaning set forth in the Preamble.

  • BMS means the Company, all related companies, affiliates, subsidiaries, parents, successors, assigns and all organizations acquired by the foregoing.

  • UBC means the University of British Columbia.

  • Merck has the meaning set forth in the preamble.

  • Pfizer shall have the meaning set forth in the preamble.

  • PTC means the tax credit for electricity produced from certain renewable generation resources described in Section 45 of the Internal Revenue Code of 1986, as it may be amended or supplemented from time to time.

  • GSK will have the meaning set forth in the Preamble.

  • DSM means the most current edition of the Diagnostic and Statistical Manual of Mental Disorders published by the American Psychiatric Association.

  • Licensee has the meaning set forth in the preamble.

  • Collaborator An individual who is not under the direct supervision of the PI (e.g., not a member of the PI’s laboratory) who assists with the PI’s research project involving controlled-access data subject to the NIH GDS Policy. Internal collaborators are employees of the Requester and work at the same location/campus as the PI. External collaborators are not employees of the Requester and/or do not work at the same location as the PI, and consequently must be independently approved to access controlled-access data subject to the NIH GDS Policy.

  • Collaboration has the meaning set forth in Section 2.1.

  • NPS means nominal pipe size.

  • the Licensee means the person(s) named in the licence.

  • Licensor Technology means the Licensor Patents and the Licensor Know-How.

  • Third Party Licensor means the relevant licensor of any Third Party Data or any Third Party Trade Xxxx;

  • Bioassay means the determination of kinds, quantities or concentrations and, in some cases, the locations of radioactive material in the human body, whether by direct measurement, in vivo counting, or by analysis and evaluation of materials excreted or removed from the human body. For purposes of these rules, “radiobioassay” is an equivalent term.

  • Shire means Shire of Augusta Margaret River

  • Siemens means Siemens AG (Germany) and its Affiliates.

  • Licensor means the copyright owner or entity authorized by the copyright owner that is granting the License.

  • Elan means Elan Corp and its Affiliates.

  • Sublicensee means a third party to whom LICENSEE grants a sublicense of certain rights granted to LICENSEE under this Agreement.

  • GTC means General Terms & Conditions of Contract.

  • Biomarker means a parameter or characteristic in a patient or Patient Sample, the measurement of which is useful (a) for purposes of selecting appropriate therapies or patient populations or monitoring disease susceptibility, severity or state, or monitoring therapies for such patient and/or (b) for predicting the outcome of a particular treatment of such patient.

  • Licensee Parties has the meaning ascribed to such term in Section 5.1.

  • Collaboration Compound means any of the following: (a) FG-4592, (b) any HIF Compound (other than FG-4592) that is added to this Agreement pursuant to Section 3.6, and (c) any salts, esters, complexes, chelates, crystalline and amorphous morphic forms, pegylated forms, enantiomers (excluding regioisomers), prodrugs, solvates, metabolites and catabolites of any of the foregoing ((a) or (b)).